Method for the synthesis of a benzimidazole compound
AssigneeAstraZeneca AB
InventorAnders Gustavsson
Life of this patent
Estimating the term…
Abstract
A process for the manufacture of omeprazole or esomeprazole from pyrmethyl alcohol via pyrmethyl chloride and pyrmetazole characterized in that the whole reaction sequence is carried out without any isolation or purification of intermediates. Further, the reaction is carried out in a solvent system common for the whole reaction sequence and inert to the reactants formed during the process and used in the process and comprises a water immiscible organic solvent and a specified amount of water.
Claims17
A process for the manufacture of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]-thio]-1H-benzimidazole of formula I,
- the process comprising the following reaction steps carried out in a consecutive order in a solvent system without isolation of the intermediates formed during the process:
- a) reacting (4-methoxy-3,5-dimethyl-2-pyridinyl)methyl alcohol (pyrmethyl alcohol) of formula Ia,
- with a chloro-dehydroxylating agent to obtain (4-methoxy-3,5-dimethyl-2-pyridinyl)methyl chloride (pyrmethyl chloride) of formula Ib;
- and
- b) reacting the (4-methoxy-3,5-dimethyl-2-pyridinyl)methyl chloride of formula Ib with 2-mercapto-5-methoxybenzimidazole (metmercazole) of formula Ic,
- in the presence of a base to obtain 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]thio]-1H-benzimidazole (pyrmetazole) of formula I;
- wherein the solvent system is the same for the entire reaction sequence and comprises an organic solvent selected from the group consisting of toluene, ethyl acetate and methyl chloride and an amount of water in the range of between 0.3 and 5.5 mg water per ml of the organic solvent.
Dependencies are inferred from the claim text.